Citi initiated coverage of Voyager Therapeutics (VYGR) with a Buy rating and $12 price target ... Try Now>> See today’s best-performing stocks on TipRanks >> Read More on VYGR: Voyager ...
Analyst Jack Allen of Robert W. Baird maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report), retaining the price target of $18.00. Jack Allen’s rating is based on several ...
As of November 21, 2024, the average one-year price target for Voyager Therapeutics is $17.57/share. The forecasts range from a low of $7.07 to a high of $31.50. The average price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback